Kenneth Luu

Kenneth Luu is an accomplished clinical pharmacology and toxicology expert with extensive experience in the biopharmaceutical industry. Currently serving as Vice President at AnaptysBio since January 2021, Kenneth previously held the position of Executive Director in the same field. Prior to this, Kenneth worked at AbbVie (Allergan) as Director of Pharmacometrics and at Ionis Pharmaceuticals, Inc. as Director of Clinical Pharmacology. Additional experience includes roles at Pfizer as Associate Director and Principal Scientist, as well as a Research Fellow at the National Science Foundation. Early in the career, Kenneth was an Associate Scientist at Valeant Pharmaceuticals. Kenneth holds a Bachelor of Science in Biological Sciences from UC Irvine and a Doctor of Philosophy in Pharmaceutical Sciences from the University of the Pacific.